临床研究

基于多中心的儿童颅脑创伤患者临床输血影响因素分析及预测模型构建

  • 刘威 ,
  • 侯君 ,
  • 唐龙泉 ,
  • 周鹏 ,
  • 钟艳 ,
  • 罗沁妍 ,
  • 况小雨 ,
  • 刘华 ,
  • 熊紫清 ,
  • 熊伟 ,
  • 吴承高 ,
  • 乐爱平
展开
  • 1.南昌大学第一附属医院输血医学科 (江西 南昌 330006 )
    2.抚州市第一人民医院输血科 (江西 抚州 344099 )
    3.上饶市立医院输血科 (江西 上饶 334099 )
    4.南昌市第一医院输血科 (江西 南昌 330008 )
    5.输血医学江西省重点实验室 (江西 南昌 330006 )

收稿日期: 2024-06-26

  网络出版日期: 2025-02-28

基金资助

江西省重点研发计划项目(20192ACB50014);江西省科技创新平台项目(20212BCD42006)

Analysis of influencing factors of blood transfusion in children with traumatic brain injury and construction of prediction model: A multi⁃center retrospective study

  • Wei LIU ,
  • Jun HOU ,
  • Longquan TANG ,
  • Peng ZHOU ,
  • Yan ZHONG ,
  • Qinyan LUO ,
  • Xiaoyu KUANG ,
  • Hua LIU ,
  • Ziqing XIONG ,
  • Wei XIONG ,
  • Chenggao WU ,
  • Aiping. LE
Expand
  • Department of Transfusion Medicine,the First Affiliated Hospital of Nanchang University,Nanchang 330006,Jiangxi,China

Received date: 2024-06-26

  Online published: 2025-02-28

摘要

目的 通过分析儿童创伤性颅脑损伤(traumatic brain injury, TBI)患者临床输血影响因素,建立其临床输血预测模型,以指导临床输血决策。 方法 回顾性分析4家医疗机构2015年1月1日至2022年12月31日收治的1 535例儿童TBI患者病历资料,根据患者院内是否输注红细胞将患者分为输血组和未输血组,分析两组患者间临床资料,通过logistic回归筛选患者院内输血相关危险因素,并采用列线图建立预测模型,利用ROC曲线评价模型的预测性能。 结果 输血组与未输血组患者基本资料、临床指征和实验室检测指标间均存在差异(P < 0.05)。输血组患者院内死亡率、并发症发生率、机械通气、ICU入住率、住院时间均明显高于未输血组(P < 0.05)。多因素logistic回归分析显示心率、其他骨折、治疗方式、血红蛋白(Hb)、血小板计数(Plt)、活化部分凝血活酶时间(APTT)、D-二聚体7个影响因素是TBI患者临床输血的独立危险因素。根据独立危险因素构建的临床输血预测模型ROC曲线下面积为0.95(95%CI: 0.94 ~ 0.97);校准曲线和决策曲线亦显示该模型具有良好的预测效果。 结论 心率、其他骨折、治疗方式、Hb、Plt、APTT、D-二聚体是TBI患者临床输血的独立危险因素,据此构建的预测模型具有较好预测效果,可指导临床医师输血决策,有助于提高患者救治成功率。

本文引用格式

刘威 , 侯君 , 唐龙泉 , 周鹏 , 钟艳 , 罗沁妍 , 况小雨 , 刘华 , 熊紫清 , 熊伟 , 吴承高 , 乐爱平 . 基于多中心的儿童颅脑创伤患者临床输血影响因素分析及预测模型构建[J]. 实用医学杂志, 2025 , 41(4) : 553 -560 . DOI: 10.3969/j.issn.1006-5725.2025.04.014

Abstract

Objective To develop a predictive model for guiding blood transfusion decisions in pediatric patients with traumatic brain injury (TBI) by identifying and analyzing key factors that influence blood transfusion requirements. Methods A retrospective analysis was conducted on the clinical data of 1,535 pediatric patients with TBI admitted to four medical institutions from January 1, 2015, to December 31, 2022. Patients were divided into two groups: those who received red blood cell transfusions during hospitalization and those who did not. Comparative analyses were performed on demographic, clinical, and laboratory data between these two groups. Logistic regression analysis was used to identify risk factors associated with in-hospital blood transfusion, and a predictive model was developed using a nomogram. The performance of this model was evaluated using a receiver operating characteristic (ROC) curve. Results Significant differences were observed between the blood transfusion and non-blood transfusion groups in terms of baseline demographics, clinical indicators, and laboratory test results (all P < 0.05). Patients in the blood transfusion group exhibited significantly higher in-hospital mortality, complication rates, use of mechanical ventilation, ICU admission rates, and length of stay compared to those in the non-blood transfusion group (all P < 0.05). Multivariate logistic regression analysis identified heart rate, presence of other fractures, treatment methods, hemoglobin (Hb), platelet count (Plt), activated partial thromboplastin time (APTT), and D-dimer levels as independent risk factors for blood transfusion in TBI patients. The area under the ROC curve for the blood transfusion prediction model, based on these independent risk factors, was 0.95 (95%CI: 0.94 ~ 0.97), indicating excellent predictive accuracy. Calibration and decision curves further validated the robustness and reliability of the model's predictive capacity. Conclusions Heart rate, presence of other fractures, treatment methods, Hb, Plt count, APTT, and D-dimer levels serve as independent risk factors for blood transfusion in TBI patients. The prediction model developed based on these factors demonstrates excellent predictive performance, thereby guiding clinicians in making informed blood transfusion decisions and enhancing the success rate of patient outcomes.

参考文献

1 国家统计局.中国统计年鉴-2021 [M]. 北京:中国统计出版社, 2021.
2 卢仁福,邱俊,孔令文,等. 8003例住院创伤患者流行病学分析[J]. 创伤外科杂志,2020,22(6):442-446.
3 TIRUNEH A, SIMAN-TOV M, GIVON A, et al. Comparison between traumatic brain injury with and without concomitant injuries: An analysis based on a national trauma registry 2008-2016 [J]. Brain Inj, 2020, 34(2): 213-223. doi:10.1080/02699052.2019.1683893
4 中华医学会神经外科学分会颅脑创伤专业组,中华医学会创伤学分会神经损伤专业组. 儿童颅脑创伤诊治中国专家共识[J]. 中华神经外科杂志, 2021, 37(12):1200-1208.
5 王衍刚,张俊杰,杜顺利,等. 不同年龄段小儿急性颅脑损伤临床特点分析[J]. 中华卫生应急电子杂志,2019,5(2):104-109.
6 肖昆,赵斐,唐斌,等. 输注不同储存时间红细胞对创伤性脑损伤患者预后的影响[J]. 实用医学杂志,2020,36(5):608-612.
7 SIGURDSSON T S, ?BERG E, ROSHAUW J, et al. A survey on perioperative red blood cell transfusion trigger strategies for pediatric patients in the Nordic countries [J]. Acta Anaesthesiol Scand, 2024,68(6):764-771. doi:10.1111/aas.14416
8 BERGUS K C, PATTERSON K N, ASTI L, et al. Association of initial assessment variables and mortality in severe pediatric traumatic brain injury [J]. World J Pediatr Surg, 2024,7(2):e000718. doi:10.1136/wjps-2023-000718
9 HE Y, XU J, SHANG X, et al. Clinical characteristics and risk factors associated with ICU-acquired infections in sepsis: A retrospective cohort study [J]. Front Cell Infect Microbiol, 2022, 12:962470. doi:10.3389/fcimb.2022.962470
10 MAZZEFFI M A, HOLMES S D, TAYLOR B, et al. Red Blood Cell Transfusion and Postoperative Infection in Patients Having Coronary Artery Bypass Grafting Surgery: An Analysis of the Society of Thoracic Surgeons Adult Cardiac Surgery Database [J]. Anesth Analg, 2022, 135(3):558-566. doi:10.1213/ane.0000000000005920
11 HOFFMANN I, LEWIS E R, MARINI C, et al. Venous thromboembolism risk among pediatric patients with traumatic brain injury: A nationwide study of 44,128 patients [J]. J Neurosurg Pediatr, 2023, 32(3):285-293. doi:10.3171/2023.4.peds23102
12 洪尉师,张亚鑫,林群,等. 髋关节翻修术后输血的危险因素分析及列线图预测模型建立[J]. 实用医学杂志,2022,38(13):1652-1656.
13 吴承高,刘强,熊伟,等. 重度颅脑创伤患者临床输血预测模型构建[J]. 中国输血杂志,2023,36(11):990-994.
14 CHEGONDI M, HERNANDEZ RIVERA J F, ALKHOURY F, et al. The need for blood transfusion therapy is associated with increased mortality in children with traumatic brain injury [J]. PLoS One, 2023, 18(1):e0279709. doi:10.1371/journal.pone.0279709
15 蒙斯雅,李梅,李微. 构建Logistic回归预测模型分析颅脑损伤患者并发凝血功能障碍的影响因素[J]. 中国急救复苏与灾害医学杂志,2023,18(3):320-324.
16 LIER H, FRIES D. Emergency Blood Transfusion for Trauma and Perioperative Resuscitation: Standard of Care [J]. Transfus Med Hemother, 2021, 48(6):366-376. doi:10.1159/000519696
17 MAEGELE M. Coagulopathy and Progression of Intracranial Hemorrhage in Traumatic Brain Injury: Mechanisms, Impact, and Therapeutic Considerations [J]. Neurosurgery, 2021, 89(6): 954-966. doi:10.1093/neuros/nyab358
18 ROSSAINT R, AFSHARI A, BOUILLON B, et al. The European guideline on management of major bleeding and coagulopathy following trauma: Sixth edition [J]. Crit Care, 2023,7(1):80. doi:10.1186/s13054-023-04327-7
19 CRASH-2 TRIAL COLLABORATORS, SHAKUR H, ROBERTS I, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): A randomised, placebo-controlled trial [J]. Lancet, 2010, 376(9734): 23-32. doi:10.1016/s0140-6736(10)60835-5
20 COLLABORATORS CRASH-2, ROBERTS I, SHAKUR H, et al. The importance of early treatment with tranexamic acid in bleeding trauma patients: An exploratory analysis of the CRASH-2 randomised controlled trial [J]. Lancet, 2011, 377(9771):1096-1101. doi:10.1016/s0140-6736(11)60278-x
21 KUNAPAISAL T, PHUONG J, LIU Z, et al. Age, admission platelet count, and mortality in severe isolated traumatic brain injury: A retrospective cohort study [J]. Transfusion. 2023, 63(8): 1472-1480. doi:10.1111/trf.17476
文章导航

/